Longitudinal changes in epigenetic clocks predict survival in the InCHIANTI cohort

Pei-Lun Kuo,Ann Zenobia Moore,Toshiko Tanaka,Daniel W. Belsky,Ake Tzu-Hui Lu,Steve Horvath,Stefania Bandinelli,Luigi Ferrucci

DOI: https://doi.org/10.1101/2024.09.13.24313620

2024-09-15

Abstract:Importance: Cross-sectional assessment of epigenetic clocks provides information on the pace of aging. Whether longitudinal acceleration or deceleration of epigenetic clocks over time provides additional mortality prediction is unknown. Objective: To test the independent associations of baseline levels and longitudinal changes in epigenetic clocks with mortality Design: Longitudinal study Setting: InCHIANTI, a population-based study of community dwelling individuals in Tuscany, Italy. Participants: 699 InCHIANTI study participants aged 21-95 years at baseline with longitudinal measurements of DNA methylation. Exposure: Baseline levels and longitudinal changes in seven epigenetic clocks, including two first-generation clocks developed using chronological age for reference (Hannum Clock, Horvath Clock), three second-generation clocks developed using time-to-death for references (DNAmPhenoAge, DNAmGrimAge, DNAmGrimAge Version 2), and two third-generation clocks developed using longitudinal rate of change of multiple phenotypes for reference (DunedinPOAm_38, DunedinPACE). Main Outcomes and Measures: Mortality was the primary outcome. Cox regression was used to estimate independent associations of baseline and longitudinal changes in epigenetic clocks with mortality. Results: Adjusting for age, sex, study sites, and epigenetic clock at the baseline, longitudinal changes of the following epigenetic clocks were associated with mortality: Hannum clock (aHR = 1.14, 95% CI:[1.03, 1.26]), DNAmPhenoAge (aHR = 1.23, 95% CI: [1.10,1.37]), DNAmGrimAge (aHR = 1.13, 95% CI: [1.02,1.26]), DNAmGrimAge Version 2 (aHR = 1.18, 95% CI:[1.06,1.31]), and DunedinPOAm_38 (aHR = 1.15, 95%CI: [1.01,1.30]). Conclusions and Relevance: Our findings confirm that epigenetic clocks capture a dimension of health that is predictive of mortality and add the notion that time changes of epigenetic age reflect changes in health that additionally and independently contribute to mortality prediction. Future studies should test whether interventions that slow down the rate of epigenetic aging are associated with longer healthspan and lifespan.

Geriatric Medicine

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **Is the rate of change of the epigenetic clock related to differential mortality?**

Specifically, what the researchers wanted to verify was whether the longitudinal change of the epigenetic clock could independently predict an individual's survival status after considering the baseline epigenetic age and other potential confounding factors. Through this study, they hoped to gain a deeper understanding of the role of epigenetics in the human aging process and explore the possibility of these epigenetic markers as predictors of health and longevity.

The paper used multiple epigenetic clocks (such as Hannum clock, DNAmPhenoAge, DNAmGrimAge, etc.). By analyzing 24 - year - long data of 699 adults in the Italian InCHIANTI cohort study, the researchers found that a faster longitudinal change of the epigenetic clock was significantly associated with a higher mortality rate. This indicates that, in addition to the baseline epigenetic age, the change of the epigenetic clock over time also independently predicts the risk of death. This finding is of great significance for future intervention measures, that is, slowing down the rate of epigenetic aging may help to extend healthy lifespan and total lifespan.